市场调查报告书
商品编码
1198561
天气预报市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)Synoptophore Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内,同视素市场预计将以 4% 左右的复合年增长率增长。
COVID-19 大流行导致医疗保健服务缩减了他们的眼保健活动,因为眼科检查程序涉及与患者的密切互动,增加了感染风险。 美国眼科学会 (AAO) 建议眼科医生暂停非紧急护理。 AAPOS 对 416 名会员进行的 2021 年会员调查发现,在 COVID-19 大流行期间,儿科眼科实践受到了毁灭性的潜在影响。 儿童没有在正确的时间得到正确的治疗,阻碍了整个市场,因为非必要的眼科诊所就诊受到限制。
所研究市场的增长主要归因于视力障碍发病率的增加、人们对视力障碍早期诊断意识的提高以及对非侵入性过程的需求不断增长。
由于视觉障碍的增加,对同视眼的需求也在增加。 此外,随着时间的推移,与视力障碍相关的中风和颅脑外伤等风险因素也在增加。 Synoptophor 的设备被认为对于纠正此类损伤非常可靠。 根据美国国家眼科研究所 (NEI) 2021 年的统计数据,大约 5% 至 16% 的人患有充血障碍 (CI) 障碍。 年轻人和成年人更容易出现视力障碍,从而促进了研究市场的增长。
人们对视力障碍早期诊断意识的提高预计将推动市场增长。 一些骨科协会鼓励视力障碍的早期诊断,这推动了对视觉设备的需求。 根据国际正畸医师协会(IOA)2021年的一篇文章,巴西正畸医师协会将6月的第一个星期一定为“世界正畸日”。 根据国际防盲协会 (IAPB) 的说法,世界视觉日 (WSD) 是一年一度的宣传日,旨在引起全球对失明和视力障碍的关注。 这些努力促进了视力障碍的早期诊断,增加了对 Synopsys 的需求。
然而,同视设备的高成本和用于治疗视力障碍的替代药物的可用性是阻碍市场增长的因素。
根据应用,预计治疗领域在预测期内将出现显着增长。 同视机是主要用于治疗眼球运动障碍的设备。 它提供了最全面的双眼视力评估,并且非常可靠。 标准测量允许在存在视网膜对应异常和水平、垂直和扭转眼部未对准的情况下评估融合幅度、同时感知和立体视觉。
2021 年 IEEE 会议表明,同视光眼越来越多地用于双眼视觉 (BV)。 Synopphor 评估三个等级的 BV。 根据美国眼科学会 (AAO) 2020 年的统计数据,儿童各向异性弱视的患病率约为 5.2%。 弱视也是发达国家儿童和成人低视力的最常见原因,发病率为 3-6%。 遮盖疗法的成功率不是很高,通过使用刺激弱视眼的同视光眼可以大大提高视力。 因此,对联视器的需求有助于治疗医疗设施中的视力障碍。
由于上述原因,预计该行业在预测期内将显着增长。
在北美,预计美国市场在预测期内将显着增长。 该国市场增长的主要驱动力是斜视和弱视等视力障碍发病率的增加,以及对非手术治疗程序的日益偏好。
根据 Prevent Blindness 2021 年的统计数据,在美国,永久性视力丧失的女性比男性多 3 人,比例为每 2 名男性对应 3 名女性。. 这推动了使用同视光眼矫正视力的采用。 此外,由于该地区的研究和开发不断增加,预计对同视光眼的需求也会增加。 例如,在美国,根据防盲研究所 (RPB) 的 2021 年更新,37 个领先的科学机构正在提供主要的眼科研究经费和视觉科学家从事多种疾病导向研究的工作。我支持. 此外,北美技术先进的基础设施有望刺激先进的自动化概要设备的生产。
由于上述原因,预计北美的同视词市场在预测期内将显着增长。
由于多个区域和全球参与者的存在,同视镜市场在很大程度上是分散的。 这些参与者专注于增长战略,例如新产品发布、现有产品创新和併购。 全球市场的主要市场参与者有 HAGG-STREIT GROUP、APPASAMY ASSOCIATES、Prkamya Visions、南京红太阳光学、Rumax International、Gem Opticals Instruments Instruments 等。 这些参与者还建立战略联盟,例如收购和合作伙伴关係,以确保其在全球市场中的地位。
The synoptophore market is projected to register a CAGR of around 4% during the forecast period.
The COVID-19 pandemic caused healthcare services to reduce eye care activities, as examination procedures in ophthalmology involve close interactions with the patients, which increases the risk of infection. The American Academy of Ophthalmology (AAO recommended ophthalmologists halt non-emergency care. According to a 2021 membership survey of 416 members conducted by the AAPOS, devastating and potential impacts were observed on pediatric ophthalmology practices during the COVID-19 pandemic. Children could not get proper treatment at the right time due to restrictions on non-essential visits to eye clinics, which hampered the overall market.
The growth of the studied market can be largely attributed to the increasing incidences of visual acuity disorders, growing awareness about the early diagnosis of visual acuity disorders, and the rising demand for non-invasive processes.
Increasing incidences of visual acuity disorders contribute to the rising demand for synoptophore. Risk factors, such as stroke and traumatic head injury, associated with visual acuity disorders also increased over time. Synoptophore devices are considered reliable for the correction of such disorders. As per the 2021 statistics by the National Eye Institute (NEI), around 5% to 16% of people suffer from convergence insufficiency (CI) disorder. The young and adult population is more prone to visual acuity disorders, which augments the growth of the market studied.
Growing awareness about the early diagnosis of acuity disorders is anticipated to fuel market growth. Several orthoptic associations encourage the early diagnosis of acuity disorders, which fuels the demand for synoptophore devices. As per a 2021 article by the International Orthoptic Association (IOA), the Brazilian Orthoptic Association determines the first Monday in June as the "World Orthoptic Day." According to the International Agency for the Prevention of Blindness (IAPB), World Sight Day (WSD) is an annual day of awareness held to focus global attention on blindness and vision impairment. Such initiatives increase the early diagnosis of visual acuity disorders, thereby propelling the demand for synoptophore.
However, the high cost of synoptophore devices and access to alternatives for treating visual acuity disorders are some factors impeding the market growth.
By application, the therapeutic segment is expected to witness significant growth over the forecast period. Synoptophore device is majorly used in the treatment of ocular motility disorders. It performs the most comprehensive binocular vision assessment and is reliable. Standard measurements allow assessment of fusional amplitudes, simultaneous perception, and stereopsis in case of abnormal retinal correspondence or horizontal, vertical, or torsional ocular misalignment.
A 2021 IEEE Conference revealed that synoptophore is increasingly used for binocular vision (BV). Synoptophore evaluates three grades of BV. As per the 2020 statistics by the American Academy of Ophthalmology (AAO), the prevalence of anisometropic amblyopia is about 5.2% in children. As per the same source, amblyopia is the most common cause of low visual acuity in children and adults in developed countries, with an incidence of 3% to 6%. The success rate via occlusion therapy is not very promising, and vision is improved to a high degree using a synoptophore to stimulate the amblyopic eye. Therefore, the demand for synoptophore devices helps healthcare facilities treat visual acuity disorders.
Thus, given the above-mentioned factors, the segment is expected to grow significantly over the forecast period.
In North America, the market in the United States is anticipated to witness significant growth over the forecast period. Major factors contributing to the growth of the market in the country are the increasing incidence of visual acuity disorders, such as strabismus and amblyopia, and the rising inclination for non-surgical treatment procedures.
As per the 2021 statistics by Prevent Blindness, in the United States, more females than males experience permanent vision loss in the ratio of 3 females for every 2 males. This fuels the adoption of vision correction using synoptophore. Moreover, increasing research and development in the region is anticipated to fuel the demand for synoptophore devices. For instance, in the United States, as per a 2021 update by the Research to Prevent Blindness (RPB), it provides major eye research funding to 37 leading scientific institutions and supports the work of vision scientists engaged in a diverse range of disease-oriented research. Furthermore, the technologically advanced infrastructure of North America is anticipated to fuel the production of advanced automatic synoptophore devices.
Thus, given the above-mentioned factors, the synoptophore market is anticipated to grow significantly over the forecast period in North America.
The synoptophore market is nearly fragmented due to the presence of several regional and global market players. These players focus on growth strategies, such as new product launches, innovations in existing products, and mergers and acquisitions. Key market players in the global market are HAGG-STREIT GROUP, APPASAMY ASSOCIATES, Prkamya Visions, Nanjing Redsun Optical Co., Ltd, Rumax International, and Gem Opticals Instruments Industries. These players are also involved in strategic alliances, such as acquisitions and collaborations, to secure their position in the global market.